Participants were recruited from the Università Europea di Roma through advertisements posted at the university. The enrollment lasted from October 2015 to March 2016. Ninety-five subjects who agreed to participate were administered the 20-item Toronto Alexithymia Scale (TAS-20)2223, the revised version of Symptom Check list 90 (SCL-90-R)24 and a checklist assessing socio-demographic data and the study inclusion criteria. Inclusion criteria were: right handedness; no history of medical, psychiatric and neurologic diseases; head trauma; no assumption of Central Nervous System active drugs in the two weeks prior to study entry.
